Blog
RSS FeedPosted by Michael Wonder on 29 Nov 2020
Drug change not ruled out as factor in epilepsy death, neurologist's report says
29 November 2020 - The first official recognition that changing brands of epilepsy drugs may have been a factor in at ...
Posted by Michael Wonder on 22 Jul 2020
Epilepsy medicine linked to deaths not same as previous funded drug — advocacy group
22 July 2020 - Testing commissioned by Patient Voice Aotearoa, a patient advocacy group, shows the three medicines given in New ...
Posted by Michael Wonder on 20 Jul 2020
Grieving families lobby Parliament to reverse epilepsy drug brand switch
21 July 2020 - It has been more than nine months since PHARMAC switched to funding epilepsy drug Logem – a ...
Posted by Michael Wonder on 13 Jul 2020
Doctors and patients anxious after pharma giant Apotex quits New Zealand
13 July 2020 - A patient advocate group says a pharmaceutical giant's decision to pull out of the New Zealand ...
Posted by Michael Wonder on 05 Jul 2020
A million Kiwis to be impacted by major pharmaceutical company leaving New Zealand
3 July 2020 - More than a million Kiwis may need to change to different medications before the end of ...
Posted by Michael Wonder on 20 May 2020
Atomoxetine – further delay in change of funded brand and open access
20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...
Posted by Michael Wonder on 30 Apr 2020
Commonwealth fails in its claim for compensation for delayed PBS listing of generic clopidogrel
29 April 2020 - The decision highlights the inherent difficulty Courts face in cases involving claims on the Usual Undertaking. ...
Posted by Michael Wonder on 09 Mar 2020
Reports of epilepsy drug harm increase 30-fold since PHARMAC switches brands
7 March 2020 - Reports of people harmed while taking epilepsy drugs is 30 times what it was before PHARMAC ...
Posted by Michael Wonder on 25 Jan 2020
Bipolar disorder patients suffer 'terrible' side effects after PHARMAC drug brand switch
25 January 2020 - A woman with bipolar disorder says she was "crying everyday" and having thoughts of suicide after ...
Posted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...
Posted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...